Dr. Myriam Abdennadher, MD

Dr. Abdennadher practices at Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System.

Dr. Abdennadher's NPI, 1407290133, was assigned on April 24, 2013. Dr. Abdennadher holds Maine license MD21619.

Dr. Abdennadher's primary practice is Boston Medical Center, at 1 Boston Medical Center Place, Boston, MA 02118 in Suffolk County. The practice phone is (617) 638-8000.

Dr. Abdennadher's primary practice is Boston Medical Center in Boston, Massachusetts, part of Boston Medical Center Health System. Dr. Abdennadher is also affiliated with Brigham and Women's Hospital. The medical group on file is Boston University Neurology Associates. Dmand AI also links Dr. Abdennadher to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdennadher practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Abdennadher's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Abdennadher's licenses on file in 2 states: Maine and Massachusetts.

CMS data shows 414 Medicare services from Dr. Abdennadher across 10 procedure codes in 2024, for 215 Medicare patients. Medicare paid $48,283 for them.

CMS counts 215 Medicare patients who saw Dr. Abdennadher in 2024. The largest group is under 65, with 106 patients. 66% of them have high blood pressure, and 57% have high cholesterol. 78% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdennadher's median patient age at 52, with 50% women.

In 2024, Dr. Abdennadher wrote 2,927 Medicare Part D claims for 193 patients. 76% of them were for generic drugs. CMS names the drug for 2,804 of them, across 45 drugs with 11 or more claims each, at $1,247,592 in total drug cost. In 2023, CMS named 3,014 claims across 47 drugs.

Dr. Abdennadher accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abdennadher as offering telehealth.

Dmand AI links 19 papers to Dr. Abdennadher, published from 2013 to 2024. 2023 was the busiest year, with 4. The most frequent topics are Seizures, Electroencephalography and COVID-19. Dr. Abdennadher has published most often in Ann Neurol. Dr. Abdennadher's most frequent co-authors are William Harold Theodore, MD, Anna M. Cervantes-Arslanian, MD and Eliot S. Katz, MD.

CMS Open Payments shows 17 general payments to Dr. Abdennadher from 12 drug and device companies from 2019 to 2024. Food and beverage make up the largest share, 99% of the total. DIXI Medical USA Corp paid the most, $833.